Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa John Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland NYU Langone Medical Center, New York, New York Penn Medicine - Otorhinolaryngology - Head and Neck Surgery Perelman, Philadelphia, Pennsylvania